Ischemia Modified Albumin Protein (IMA)

Produktnummer ABIN1877197

Produktdetails

Target: Ischemia Modified Albumin (IMA)

Protein-Typ: Native

Spezies: Human

Quelle: Human

Applikation: SDS-PAGE (SDS), Western Blotting (WB), Immunogen (Imm), Positive Control (PC)

Reinheit: > 90 %

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Kommentare:

Isoelectric Point:

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution: Reconstitute in sterile PBS, pH 7.2 - pH 7.4.

Buffer: 20 mM Tris, 150 mM NaCl, pH 8.0, containing 1 mM EDTA, 1 mM DTT, 0.01 % SKL, 5 % Trehalose and Proclin300.

Konservierungsmittel: ProClin

Handhabung: Avoid repeated freeze/thaw cycles

Lagerung: 4 °C,-80 °C

Informationen zur Lagerung: Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

Haltbarkeit: 12 months

Antigendetails

Target: Ischemia Modified Albumin (IMA)

Andere Bezeichnung: Ischemia Modified Albumin (IMA Produkte)

Hintergrund: Ischemia Modified Albumin is also called Human serum albumin. Human serum albumin is the most abundant protein in human blood plasma. It is produced in the liver. Albumin constitutes about half of the blood serum protein. It is soluble and monomeric. Albumin is synthesized in the liver as preproalbumin, which has an N-terminal peptide that is removed before the nascent protein is released from the rough endoplasmic reticulum. It has a molecular mass of 67 kDa. Human albumin is often used to replace lost fluid and help restore blood volume in trauma, burns and surgery patients. A Cochrane systematic review[6] of 37 trials found no evidence that albumin, compared with cheaper alternatives such as saline, reduces the risk of dying.

Molekulargewicht: 68 kDa